CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain

  • Chew L
  • Khanna R
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Neuropathic pain represents a significant and mounting burden on patients and society at large. Management of neuropathic pain, however, is both intricate and challenging, exacerbated by the limited quantity and quality of clinically available treatments. On this stage, dys-functional voltage-gated ion channels, especially the presynaptic N-type voltage-gated calcium channel (VGCC) (Cav2.2) and the tetrodotoxin-sensitive voltage-gated sodium channel (VGSC) (Nav1.7), underlie the pathophysiology of neuropathic pain and serve as high profile therapeutic targets. Indirect regulation of these channels holds promise for the treatment of neuropathic pain. In this review, we focus on collapsin response mediator protein 2 (CRMP2), a protein with emergent roles in voltage-gated ion channel trafficking and discuss the therapeutic potential of targetting this protein.

Cite

CITATION STYLE

APA

Chew, L. A., & Khanna, R. (2018). CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain. Neuronal Signaling, 2(1), NS20170220. https://doi.org/10.1042/ns20170220

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free